Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose intramuscular TV-1380 in healthy volunteers
NL-OMON35366Active, not recruiting
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Nov 2011
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Double-blind trial of TV-1380 in cocaine use disorder (CUD) and cocaine intoxication (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Serum TV-1380 concentrations, Pharmacokinetic parameters and 10 more. Started Nov 2011; status: active, not recruiting.
02
Drugs
TV-1380
03
Conditions
cocaine use disorder (CUD)cocaine intoxication
Beyond the preview
Go deeper on NL-OMON35366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35366.